Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.49 |
| _version_ | 1797234799688024064 |
|---|---|
| author | Mei‐Jing Liu Kai‐Wen Tan Han‐Yu Cao Si‐Man Huang Chong‐Sheng Qian Sheng‐Li Xue Hai‐Ping Dai Wen‐Jie Gong |
| author_facet | Mei‐Jing Liu Kai‐Wen Tan Han‐Yu Cao Si‐Man Huang Chong‐Sheng Qian Sheng‐Li Xue Hai‐Ping Dai Wen‐Jie Gong |
| author_sort | Mei‐Jing Liu |
| collection | DOAJ |
| first_indexed | 2024-03-07T19:48:51Z |
| format | Article |
| id | doaj.art-e67c1d859b3b44b58dbb7e4039eecb71 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-04-24T16:37:48Z |
| publishDate | 2024-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-e67c1d859b3b44b58dbb7e4039eecb712024-03-29T13:51:20ZengWileyHemaSphere2572-92412024-02-0182n/an/a10.1002/hem3.49Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemiaMei‐Jing Liu0Kai‐Wen Tan1Han‐Yu Cao2Si‐Man Huang3Chong‐Sheng Qian4Sheng‐Li Xue5Hai‐Ping Dai6Wen‐Jie Gong7National Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou People's Republic of ChinaNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou People's Republic of ChinaNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou People's Republic of ChinaNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou People's Republic of ChinaNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou People's Republic of ChinaNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou People's Republic of ChinaNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou People's Republic of ChinaNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University Suzhou People's Republic of Chinahttps://doi.org/10.1002/hem3.49 |
| spellingShingle | Mei‐Jing Liu Kai‐Wen Tan Han‐Yu Cao Si‐Man Huang Chong‐Sheng Qian Sheng‐Li Xue Hai‐Ping Dai Wen‐Jie Gong Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia HemaSphere |
| title | Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia |
| title_full | Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia |
| title_fullStr | Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia |
| title_full_unstemmed | Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia |
| title_short | Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia |
| title_sort | patients with cml in the lymphoid blastic phase have inferior response to anti cd19 car t cell therapy compared to de novo ph positive b cell acute lymphoblastic leukemia |
| url | https://doi.org/10.1002/hem3.49 |
| work_keys_str_mv | AT meijingliu patientswithcmlinthelymphoidblasticphasehaveinferiorresponsetoanticd19cartcelltherapycomparedtodenovophpositivebcellacutelymphoblasticleukemia AT kaiwentan patientswithcmlinthelymphoidblasticphasehaveinferiorresponsetoanticd19cartcelltherapycomparedtodenovophpositivebcellacutelymphoblasticleukemia AT hanyucao patientswithcmlinthelymphoidblasticphasehaveinferiorresponsetoanticd19cartcelltherapycomparedtodenovophpositivebcellacutelymphoblasticleukemia AT simanhuang patientswithcmlinthelymphoidblasticphasehaveinferiorresponsetoanticd19cartcelltherapycomparedtodenovophpositivebcellacutelymphoblasticleukemia AT chongshengqian patientswithcmlinthelymphoidblasticphasehaveinferiorresponsetoanticd19cartcelltherapycomparedtodenovophpositivebcellacutelymphoblasticleukemia AT shenglixue patientswithcmlinthelymphoidblasticphasehaveinferiorresponsetoanticd19cartcelltherapycomparedtodenovophpositivebcellacutelymphoblasticleukemia AT haipingdai patientswithcmlinthelymphoidblasticphasehaveinferiorresponsetoanticd19cartcelltherapycomparedtodenovophpositivebcellacutelymphoblasticleukemia AT wenjiegong patientswithcmlinthelymphoidblasticphasehaveinferiorresponsetoanticd19cartcelltherapycomparedtodenovophpositivebcellacutelymphoblasticleukemia |